Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia
Abstract Background As a key inflammatory factor, the nucleotide-binding oligomerization domain (NOD)-like receptor protein 3 (NLRP3) inflammasome plays a crucial role in neuroinflammation and the progression of neurodegenerative diseases. Dysregulation of NLRP3 signaling can trigger various inflamm...
Saved in:
| Main Authors: | Adnan Akif, Thi Thanh My Nguyen, Langni Liu, Xiaotian Xu, Amol Kulkarni, Jianxiong Jiang, Yang Zhang, Jiukuan Hao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-06-01
|
| Series: | Fluids and Barriers of the CNS |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12987-025-00665-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats
by: Qing Li, et al.
Published: (2025-04-01) -
NLRP12-associated periodic syndrome: A description of the authors' own observation and an analysis of literature data
by: M. F. Dubko, et al.
Published: (2017-04-01) -
NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01) -
NOD2-NLRP3 Axis and Asthma
by: Cai X
Published: (2025-05-01) -
Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations
by: Mengxue Wang, et al.
Published: (2025-05-01)